RheumaWise

Clinical Pearl

RF vs Anti-CCP

Published: July 2026

RF vs Anti-CCP Infographic

Understanding RF and Anti-CCP

Rheumatoid Factor (RF) and Anti-Cyclic Citrullinated Peptide (Anti-CCP) antibodies are two of the most commonly ordered blood tests when evaluating patients with suspected rheumatoid arthritis (RA). Although both are associated with RA, they provide different clinical information and should always be interpreted together with the patient's symptoms, physical examination, and imaging findings.

What is Rheumatoid Factor (RF)?

Rheumatoid Factor is an autoantibody directed against the Fc portion of IgG antibodies. It has been used for many years as part of the evaluation of rheumatoid arthritis.

  • Present in approximately 70–80% of patients with rheumatoid arthritis.
  • Less specific than Anti-CCP.
  • Can also be positive in Sjögren syndrome, hepatitis C, chronic infections, and even healthy older adults.
  • A negative RF does not rule out rheumatoid arthritis.

What is Anti-CCP?

Anti-CCP antibodies recognize citrullinated proteins that develop during inflammation. These antibodies are highly specific for rheumatoid arthritis and may become positive early in the disease.

  • Specificity greater than 95% for rheumatoid arthritis.
  • May become positive before symptoms appear.
  • Associated with erosive disease and a more aggressive clinical course.
  • Supports the diagnosis when interpreted with clinical findings.

When should these tests be ordered?

These blood tests are useful when a patient has symptoms suggestive of inflammatory arthritis, including:

  • Persistent joint pain
  • Morning stiffness lasting more than 30 minutes
  • Swollen joints
  • Symmetrical involvement of the small joints of the hands and feet
  • Elevated ESR or CRP

Can someone have rheumatoid arthritis if both tests are negative?

Yes. Approximately 20–30% of patients have seronegative rheumatoid arthritis, meaning both RF and Anti-CCP are negative. In these patients, the diagnosis relies on the clinical history, physical examination, imaging studies, and follow-up over time.

Clinical Pearl

A positive Anti-CCP antibody strongly supports the diagnosis of rheumatoid arthritis, but no blood test alone can confirm or exclude RA. Rheumatoid arthritis remains a clinical diagnosis based on the patient's symptoms, physical examination, laboratory findings, and imaging.

References

  1. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
  2. EULAR Recommendations for the Management of Rheumatoid Arthritis.
  3. UpToDate: Diagnosis and Differential Diagnosis of Rheumatoid Arthritis.